Metraipolis › archive › dc_3ce1560206cb

Anifrolumab for Nonsystemic Cutaneous Lupus Erythematosus: Clinical Experience, Immunologic Insights, and Review of the Literature — Europe PMC PMID:40869510

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40869510
DOI
10.3390/jcm14165683
License (as archived)
solo-consultazione
Archived
2026-11-10T18:08:47.209Z
SHA-256 of the archived text
d14c516c6c8ed4d41bbc5492a9f16da7ebd2f2aa18a2201a1c20089cf6377922
Stable URL of this page
https://metraipolis.com/documento/dc_3ce1560206cb

How to cite

Anifrolumab for Nonsystemic Cutaneous Lupus Erythematosus: Clinical Experience, Immunologic Insights, and Review of the Literature — Europe PMC PMID:40869510 — Europe PMC (en), https://europepmc.org/article/MED/40869510 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3ce1560206cb (Metraipolis archive dc_3ce1560206cb, sha256 d14c516c6c8ed4d41bbc5492a9f16da7ebd2f2aa18a2201a1c20089cf6377922)
BibTeX
@misc{dc3ce1560206cb,
  title = {Anifrolumab for Nonsystemic Cutaneous Lupus Erythematosus: Clinical Experience, Immunologic Insights, and Review of the Literature — Europe PMC PMID:40869510},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40869510},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3ce1560206cb; sha256 d14c516c6c8ed4d41bbc5492a9f16da7ebd2f2aa18a2201a1c20089cf6377922},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40869510. Agents can read the archived copy with the MCP tool read_document.